Executive Summary
Across 50 filings dominated by financial institutions (30+), Q1 2026 results show YoY net income growth averaging +25% in outperformers like Franklin Financial (+69%) and Univest (+25%), but QoQ declines in 6/12 banks (avg -6%), with NIM mixed: expansions +13-48bps YoY in CVB/Franklin vs compressions -5-11bps QoQ in CVB/First Citizens. Healthcare/biotech filings (8: Edgewise, Caris, Thermo Fisher, Minerva, SELLAS, Solid, Inhibrx, Lifeward) are mostly neutral proxy statements for June 3-16 annual meetings, lacking financial trends but highlighting governance enhancements. Capital allocation bullish: 10+ firms hiked dividends (avg +8%, e.g., Esquire +14%, Principal +8%), repurchases total $12B+ (Newmont $6B auth, Thermo $3B executed, Bread $690M auth), signaling conviction amid $200B+ deposit/loan growth QoQ. M&A active: GCI $310M Quintillion (healthcare wholesale support), CVB Heritage completion Apr17, Axos IRA from Capital One, Burke & Herbert LINKBANCORP May1 close. Forward guidance stable/positive (Bread low-single digit growth/7.2-7.4% loss rate; Newmont 5.3M oz gold), but mixed sentiment (18/50) from provision hikes/NPA rises. Portfolio trend: Banks ROA/ROE 1.2-1.4%/12-16%, provisions up YoY signaling credit stress; healthcare routine, no major catalysts. Implications: Buy dividend growth banks, monitor NIM/provisions for rotation; biotech proxies low alpha unless share increases pass (Solid +100% auth shares).
Tracking the trend? Catch up on the prior S&P 500 Healthcare Sector SEC Filings digest from April 16, 2026.
Investment Signals(12)
- Bread Financial↓(BULLISH)▲
Net income +32% YoY to $181M, revenue +5% to $1.018B, credit sales +7% to $6.5B, delinquency -34bps to 5.59%, repurchased 3.5M shares/$150M, $690M buyback auth, 2026 guidance low-single digit loan/revenue growth
- Thermo Fisher Scientific↓(BULLISH)▲
Q1 revenue +6% YoY to $11.01B (organic +1%, acq +3%), adj EPS +6% to $5.44, Life Sciences +13%, acquired Clario, repurchased $3B shares, dividend +10%
- Esquire Financial↓(BULLISH)▲
Q1 net income +7% YoY to $12.2M, total revenue +19.8% to $40.5M, NIM resilient 6.04%, loans +$56.7M QoQ to $1.82B, deposits +$39.6M QoQ, dividend +14% to $0.20
- Univest Financial↓(BULLISH)▲
Q1 net income +24.7% YoY to $27.1M/$0.96 EPS, NII +11.6% to $63.4M, noninterest income +7.5%, dividend +4.5% to $0.23, repurchased 351K shares
- Franklin Financial↓(BULLISH)▲
Q1 net income +69.2% YoY to $6.6M/$1.48 EPS, NII +18.7% to $18.5M, NIM +48bps YoY to 3.53%, ROA +48bps to 1.20%, dividend +3% to $0.34
- Waterstone Financial↓(BULLISH)▲
Q1 net income doubled YoY to $6.0M/$0.34 EPS, Community Banking NII +22.8% to $15.2M, NIM +50bps to 2.97%, Mortgage originations +31.1% to $508.3M
- Principal Financial↓(BULLISH)▲
Q1 non-GAAP earnings +10% YoY to $456.1M/$2.17 EPS, AUM +7% to $770.2B, Specialty Benefits +29% to $136.8M, dividend +8% to $0.82 Q2, repurchased $200M
- Newmont↓(BULLISH)▲
Q1 record FCF $3.1B, net income $3.3B, Adj EBITDA $5.2B, AISC -21% QoQ to $1,029/oz, on track 5.3M oz gold FY2026, $6B buyback auth + $0.26 div
- Union Pacific↓(BULLISH)▲
Q1 net income +5% YoY to $1.7B/$2.87 EPS, operating revenue +3%, adj OR -80bps to 59.9%, freight velocity +9%, affirmed mid-single digit EPS growth FY2026
- CVB Financial↓(BULLISH)▲
Q1 NII +6.7% YoY to $117.8M, NIM +13bps YoY to 3.44%, pretax pre-provision +6% YoY, completed largest-ever Heritage acquisition Apr17
- First Business Financial↓(BULLISH)▲
Q1 loans +9.9% YoY/$315.9M, core deposits +13.5% YoY/$333.4M, non-interest income +15.8% YoY, tangible BVPS +13.6% YoY
- Burke & Herbert↓(BULLISH)▲
Q1 ROA 1.39%/ROE 12.62%, CET1 13.8%, regulatory approval for LINKBANCORP merger closing May1 2026, dividend $0.55
Risk Flags(9)
- Amalgamated Financial/Credit Quality↓[HIGH RISK]▼
Net income -5.3% QoQ to $25.2M, provision +$9.2M single multifamily reserve, NPA surge to $99.3M/1.08% assets from $28.7M
- First Citizens/Earnings↓[MEDIUM RISK]▼
Q1 net income -8% QoQ to $534M, NII -$101M to $1.62B, NIM -11bps to 3.09%, nonaccrual loans +$120M to 0.96%
- CVB Financial/Deposits↓[MEDIUM RISK]▼
Deposits -3.9% QoQ, noninterest-bearing % down to 57.76% from 59.01% YoY, provision $3.0M vs prior recaptures
- Bread Financial/Credit↓[MEDIUM RISK]▼
Provision for losses +2% to $303M despite net loss rate -83bps to 7.33%, 2026 guidance 7.2-7.4%
- Newmont/Production↓[MEDIUM RISK]▼
Gold oz -10% QoQ to 1.3M due to Boddington/Tanami/Lihir issues
- Thermo Fisher Scientific/Margins↓[MEDIUM RISK]▼
Adj operating margin -10bps to 21.8%, Analytical Instruments flat rev/-11% income, Specialty Diagnostics -0.5% rev
- Financial Institutions/Deposits↓[MEDIUM RISK]▼
Deposits -0.7% YoY from BaaS wind-down, consumer indirect loans -7.7% YoY, noninterest income -$2.1M QoQ
- Waterstone Financial/Expenses↓[LOW RISK]▼
Compensation +20.1% YoY, Mortgage gross margin -33bps to 3.65%, provision +$822K YoY to $264K
- Esquire Financial/Efficiency↓[LOW RISK]▼
Efficiency ratio +150bps to 51.1% from merger costs/stock comp, ROA -29bps to 2.10%, provision +$1.2M YoY
Opportunities(8)
- Bread Financial/Partnerships↓(OPPORTUNITY)◆
New cards with Ford/Ethan Allen, expanded Bread Pay (AAA/Dell/Ford/Academy), loans +2% YoY to $18.1B, undervalued vs credit improvement
- GCI Liberty/M&A Synergies↓(OPPORTUNITY)◆
$310M Quintillion acq (1,800mi fiber +1,500mi expansion) boosts Alaska healthcare/education broadband, $160M loan, earnouts 2028-2031
- Thermo Fisher Scientific/M&A↓(OPPORTUNITY)◆
Clario acquisition drove 3% rev growth, goodwill +$5.8B to $55.2B, Life Sciences +13% signals integration alpha
- CVB Financial/M&A↓(OPPORTUNITY)◆
Heritage acq completed Apr17 (largest ever), loans +1.9% YoY avg, 196 qtrs profitability/146 divs, NIM +13bps
- Axos Financial/M&A↓(OPPORTUNITY)◆
Acquiring Capital One IRA custodial biz (CD/savings deposits), premium on deposits, regulatory approvals pending
- Burke & Herbert/M&A↓(OPPORTUNITY)◆
LINKBANCORP merger approved, close May1 2026, loans $5.4B stable, liquidity $4.8B, NIM 4.09% top-tier
- Edgewise Therapeutics/Governance↓(OPPORTUNITY)◆
New board add Christopher Martin (commercial exp for Becker MD launch/Phase3 CV), June4 meeting
- Solid Biosciences/Share Increase↓(OPPORTUNITY)◆
Proxy seeks +100% auth shares to 480M (from 98M outstanding), June10 vote, biotech pipeline funding
Sector Themes(6)
- Bank Dividend Hikes(POSITIVE SHAREHOLDER RETURNS)◆
8/20 financials raised divs avg +8% YoY (Esquire +14%, SB Financial +7%, Franklin +3%), yields 2.5-3%, signaling conviction amid 13-16% ROE
- NIM Divergence in Banks(MIXED PROFITABILITY)◆
6/12 expanded +20bps avg YoY (Franklin +48bps, CVB +13bps), but 5 compressed -8bps avg QoQ (First Citizens -11bps), deposits +2.5% avg QoQ but non-interest bearing down 1-2%
- Buyback Acceleration(BULLISH CAPITAL ALLOCATION)◆
$12B+ auth/executed (Newmont $6B+$2.4B done, Bread $690M, Thermo $3B, Principal $200M), post-Q1 strength, CET1 13%+ avg supports
- M&A Momentum Financial/Telecom(CONSOLIDATION ALPHA)◆
5 deals (GCI Quintillion $310M EV, CVB Heritage, Axos Capital One IRA, Burke LINKBANCORP May1, Capital One Brex closed Apr7), valuations accretive, healthcare wholesale upside
- Proxy Season Biotech/Financial(GOVERNANCE STABLE)◆
15 filings for June3-16 meetings (Edgewise/CarIs/Minerva/SELLAS/Solid/Inhibrx), routine elections/ratifications + share increases (SELLAS +20M, Solid +240M), low opposition
- Provision Pressures(CREDIT WATCH)◆
7/15 banks provisions up YoY/QoQ (Amalgamated +$9.2M, CVB $3M, Esquire +$1.2M), NPA 0.5-1% avg, but ACL/loans stable 1.1-1.3%
Watch List(8)
Q1 beat but Corp losses widened, watch deposit flows/guidance Apr24 10am ET call [Apr24 2026]
LINKBANCORP merger regulatory approved, monitor integration/deposit retention May1 close [May1 2026]
Director elections/auditor ratification/EO comp vote, Becker MD launch prep June4 Boulder [Jun4 2026]
10 directors election (board shrink to 10), Deloitte ratification, virtual June4 [Jun4 2026]
2 Class III directors, charter amends/exculpation, EO comp, Deloitte FY2026 June3 virtual [Jun3 2026]
2 Class I directors, +20M equity plan shares, Baker Tilly ratification June16 virtual [Jun16 2026]
3 Class II +1 Class I directors, +240M shares auth, PwC ratification June10 virtual [Jun10 2026]
Q1 prod miss but FY5.3M oz on track, $1.95B sustaining capex watch Q2 update [Q2 2026]
Filing Analyses(50)
23-04-2026
Edgewise Therapeutics, Inc., a late-stage biopharmaceutical company focused on muscle diseases, has filed its definitive proxy statement for the annual stockholder meeting on June 4, 2026, seeking election of three Class II directors (Laura Brege, Badreddin Edris, Ph.D., and Jonathan Root, M.D.), ratification of KPMG LLP as independent auditors for fiscal year ending December 31, 2026, and an advisory vote approving named executive officer compensation. The proxy highlights robust corporate governance practices, including annual board assessments, executive sessions of independent directors, a compensation recovery policy, and active stockholder engagement. No financial performance metrics or period-over-period comparisons are disclosed in the filing.
- ·Annual meeting location: 1715 38th Street, Boulder, Colorado 80301
- ·Record date: April 9, 2026
- ·Christopher Martin appointed to board in November 2025, bringing commercial launch experience ahead of Becker muscular dystrophy launch and Phase 3 cardiovascular asset
- ·Board structure: three staggered classes, with Class II nominees serving until 2029 annual meeting
23-04-2026
GCI Holdings, LLC, a wholly owned subsidiary of GCI Liberty, Inc. (Nasdaq: GLIBA, GLIBK), announced a definitive agreement to acquire 100% of Quintillion (Q Gateway Intermediate Holdings, LLC) for a $310 million enterprise value, subject to adjustments, including reimbursement of up to $50 million in qualifying capital expenditures for the Nome-to-Homer Express project and a $160 million unsecured loan provided shortly after signing. The deal combines Quintillion’s 1,800+ miles of existing fiber and ~1,500 miles of planned expansion with GCI’s statewide network to enhance reliability, resiliency, and performance in Alaska’s challenging environments. No financial performance declines or flat metrics are reported; the acquisition supports strategic goals like national defense and broadband expansion without noted disruptions to existing services.
- ·Closing anticipated following regulatory approval and customary conditions.
- ·Additional consideration payable in 2028, 2029, and 2031 via post-closing earnout based on financial metrics.
- ·Quintillion operates primarily on wholesale basis, supporting carriers, healthcare, education, and public safety.
- ·Press release dated April 22, 2026; SEC 8-K filed April 23, 2026.
23-04-2026
CID Holdco, Inc. filed an S-1 registration statement on April 23, 2026, disclosing board committee structures including the Cybersecurity & Technology Committee and Nominating and Corporate Governance Committee, along with director compensation policies featuring $50,000 annual cash fees and quarterly stock options valued at $20,000-$40,000. Non-employee directors earned $37,500 in cash fees and $80,000-$105,000 in option awards (not granted) for 2025, totaling $117,500-$142,500. Named Executive Officers saw total compensation rise significantly YoY to $642,884 (CEO), $514,558 (CFO/COO), and $476,154 (CTO) in 2025 from $235,821, $230,000, and $230,000 in 2024, driven by transaction bonuses of $320,000, $250,000, and $200,000 respectively.
- ·No option awards were granted to non-employee directors during 2025 despite values earned.
- ·No incentive compensation paid to NEOs in 2025 except $600 to Charles Maddox for Puerto Rico statutory bonus consistency.
- ·Base salaries increased effective July 15, 2025: CEO to $350,000, CFO/COO to $300,000, CTO to $330,000.
- ·Annual incentive bonuses eligible from September 5, 2025: $50,000 target per NEO based on performance metrics.
- ·Company does not maintain a 401(k) or other retirement savings plan.
23-04-2026
Amalgamated Financial Corp. reported strong Q1 2026 results with net revenue of $93.4 million, up 9.7% QoQ from $85.2 million, net interest margin expanding 9 basis points to 3.75%, on-balance sheet deposits growing $228.9 million or 2.9% to $8.2 billion, and net loans increasing $65.5 million or 1.3% to $5.0 billion. However, net income declined $1.4 million or 5.3% QoQ to $25.2 million, driven by provision expense rising to $13.5 million including a $9.2 million reserve for a single multifamily borrower, with nonperforming assets surging to $99.3 million or 1.08% of assets from $28.7 million. Core net income fell sharply to $24.1 million from $30.0 million.
- ·Multifamily and commercial real estate loan portfolios totaled $2.2 billion with concentration of 232% to total risk-based capital.
- ·Off-balance sheet deposits increased $71.9 million or 6.8% to $1.1 billion.
- ·Political deposits increased $132.9 million or 7.7% to $1.9 billion.
- ·Repurchased approximately 80,000 shares with $8.4 million remaining capacity under repurchase program.
- ·Tangible book value per share increased 1.6% to $26.59.
- ·Conference call held April 23, 2026 at 11:00 am ET.
23-04-2026
Bread Financial reported strong Q1 2026 financial results, with net income of $181 million (+32% YoY from $138 million), revenue up 5% to $1,018 million, and credit sales increasing 7% to $6.5 billion. End-of-period loans grew 2% YoY to $18.1 billion while average loans rose modestly 1% to $18.3 billion; credit metrics improved with delinquency rate down 34 bps to 5.59% and net loss rate down 83 bps to 7.33%, though provision for credit losses increased 2% to $303 million. The company repurchased 3.5 million shares (including 2.0 million for $150 million) and increased its repurchase authorization by $600 million to $690 million, maintaining CET1 ratio at 13.3%.
- ·Launched new credit card relationships with Ford and Ethan Allen; expanded Bread Pay with AAA, Dell, Ford, and Academy Sports.
- ·2026 full-year outlook: average loan growth low single digits; total revenue growth low single digits; net loss rate 7.2%-7.4%; effective tax rate 25%-27%.
- ·Repurchased $50 million subordinated debt, $350 million principal outstanding.
- ·Reserve rate improved 73 bps YoY to 11.46%.
- ·Direct-to-consumer deposits averaged 48% of total funding (up from 43% YoY).
23-04-2026
Newmont reported record Q1 2026 results including $3.1 billion free cash flow, $3.3 billion net income, and Adjusted EBITDA of $5.2 billion, driven by high gold prices of $4,900/oz and lower AISC of $1,029/oz (down 21% QoQ), while producing 1.3 million attributable gold ounces (down 10% QoQ due to issues at Boddington, Tanami, Lihir, Cerro Negro, and non-managed JVs). The company is on track for full-year 2026 gold guidance of 5.3 million ounces, declared a $0.26/share dividend, and authorized an additional $6.0 billion share repurchase program after executing $2.4 billion since the last earnings call. Strong cash position of $8.8 billion and net cash of $3.2 billion supports the enhanced capital allocation framework.
- ·Full-year 2026 sustaining capital guidance: $1.95 billion
- ·Full-year 2026 development capital guidance: $1.4 billion
- ·Full-year 2026 gold production guidance: 5.3 million attributable ounces
- ·Annual dividend commitment: $1.1 billion, indicated annualized $1.04 per share
- ·Copper production: 30 thousand tonnes (up 3% QoQ)
- ·Silver production: 9 million ounces (up 29% QoQ)
23-04-2026
Caris Life Sciences, Inc. (CAI) filed a DEFA14A Definitive Additional Proxy Statement with the SEC on April 23, 2026, marked as Definitive Additional Materials for proxy solicitation under Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No specific proposals, financial data, or voting matters are detailed in the provided filing header.
23-04-2026
Thermo Fisher Scientific reported first quarter 2026 revenue of $11.01 billion, up 6% YoY from $10.36 billion, with organic growth of only 1% (3% acquisitions, 2% currency) and strong performance in Life Sciences Solutions (+13%) and Laboratory Products (+7%). GAAP diluted EPS grew 11% to $4.43 and adjusted EPS increased 6% to $5.44, but adjusted operating margin dipped slightly to 21.8% from 21.9%, Analytical Instruments revenue was flat (-0.1%) with segment income down 11%, and Specialty Diagnostics revenue declined 0.5%. The company completed the acquisition of Clario, repurchased $3.0 billion in stock, and raised its dividend by 10%.
- ·Acquisitions contributed 3% to revenue growth.
- ·Currency translation contributed 2% to revenue growth.
- ·Goodwill increased to $55,187 million from $49,362 million due to Clario acquisition.
- ·Net cash provided by operating activities $1,192 million, up from $723 million.
23-04-2026
CVB Financial Corp reported Q1 2026 net earnings of $51.0 million, nearly flat YoY from $51.1 million but down 7.4% QoQ from $55.0 million amid a $3.0 million provision for credit losses versus prior recaptures. Net interest income rose 6.7% YoY to $117.8 million with NIM expanding 13 bps to 3.44%, though NII fell 3.9% and NIM contracted 5 bps QoQ; average loans grew 1.3% QoQ and 1.9% YoY while deposits increased 2.4% YoY on average. The company completed its largest-ever acquisition of Heritage Commerce Corp on April 17, 2026, with results excluded from Q1.
- ·Pretax pre-provision income grew 6% YoY by $4.0 million.
- ·Noninterest-bearing deposits averaged 57.76% of total deposits, down from 59.01% YoY.
- ·196 consecutive quarters (49 years) of profitability and 146 consecutive quarters of cash dividends.
- ·Acquisition-related expenses of $1.1 million in Q1 2026.
23-04-2026
News Corporation filed an 8-K on April 23, 2026, reporting on disclosures made to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program for Class A (NWSA) and Class B (NWS) common stock, as detailed in attached Exhibits 99.1 and 99.2. The program, previously reported, authorizes aggregate repurchases up to $1B, with daily ASX disclosures required for any transactions. The filing cautions that statements on repurchase intent are forward-looking and subject to market conditions and other risks.
- ·Date of earliest event reported: April 22, 2026
- ·Filing prepared pursuant to Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
23-04-2026
Capital One Financial Corporation filed an 8-K on April 23, 2026, to accompany a Resale Prospectus Supplement enabling selling security holders to offer and sell up to 10,345,906 shares of its common stock ($0.01 par value per share). These shares were issued as consideration for the company's acquisition of Brex Inc., which closed on April 7, 2026. The filing includes exhibits consisting of a legal opinion and consent from Wachtell, Lipton, Rosen & Katz.
- ·Resale Prospectus Supplement dated April 23, 2026, part of Form S-3 (File No. 333-277813)
- ·Securities registered include depositary shares for Series I, J, K, L, N Preferred Stock and 1.650% Senior Notes Due 2029
23-04-2026
Caris Life Sciences, Inc. has issued its 2026 Proxy Statement for the virtual Annual Meeting of Shareholders on June 4, 2026, seeking election of ten director nominees to serve until the 2027 Annual Meeting, with the board size reducing from twelve to ten following the retirement of Drs. George H. Poste and Jonathan Knowles. Shareholders are also asked to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. No financial performance metrics or changes are discussed.
- ·Record Date: Close of business on April 9, 2026
- ·Annual Meeting: Thursday, June 4, 2026, at 10:00 a.m. Central Time, virtual at www.virtualshareholdermeeting.com/CAI2026
- ·Proxy materials sent/disseminated: April 23, 2026
- ·Election requires plurality vote; board not classified (one-year terms)
23-04-2026
MSCI Inc. held its annual stockholder meeting on April 21, 2026, with 73,120,206 shares entitled to vote. All 11 director nominees were elected receiving between 60,057,776 and 63,027,070 'For' votes, with 'Against' votes ranging from 110,403 to 2,909,009; the advisory vote on executive compensation was approved with 59,076,413 'For' versus 4,061,619 'Against'; and the ratification of PricewaterhouseCoopers LLP as auditor for fiscal year 2026 passed with 65,169,698 'For' votes. All proposals received strong shareholder support with no significant opposition beyond broker non-votes of 3,158,970 on Proposals 1 and 2.
- ·Proposal 3 (auditor ratification) had no broker non-votes reported.
- ·Total votes cast on Proposal 3: 65,169,698 For; 1,132,416 Against; 101,547 Abstain.
23-04-2026
Bread Financial Holdings, Inc. filed an 8-K on April 23, 2026, under Item 7.01 Regulation FD Disclosure, announcing a press release providing a performance update as of and for the period ended March 31, 2026. The press release is furnished as Exhibit 99.1 and not deemed filed. No specific financial metrics or performance details are disclosed in the filing body.
- ·Filing includes securities details: Common Stock (BFH, NYSE); Depositary Shares Each Representing a 1/40th Interest in a Share of 8.625% Non-Cumulative Perpetual Preferred Stock, Series A (BFH PrA, NYSE).
- ·Company address: 3095 Loyalty Circle, Columbus, Ohio 43219.
- ·Date of earliest event reported: April 23, 2026.
23-04-2026
Minerva Neurosciences, Inc. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Stockholders on June 3, 2026, at 8:30 AM EDT, with voting deadline June 2, 2026, 11:59 PM ET. Key proposals include electing David Kupfer and Jan van Heek as Class III directors until the 2029 Annual Meeting, amending the Charter to allow exculpation of certain officers and eliminate the exclusive forum provision, advisory approval of named executive officer compensation, preference for 1-year say-on-pay frequency, and ratification of Deloitte & Touche LLP as auditors for FY ending December 31, 2026. The Board recommends FOR on all items except the 1-year frequency preference.
- ·Proxy materials available online at www.ProxyVote.com or request paper/email copy by May 20, 2026.
- ·Filed on April 23, 2026, as Definitive Additional Materials (no fee required).
23-04-2026
Minerva Neurosciences, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 3, 2026 at 8:30 a.m. ET. Key proposals include electing two Class III directors (Dr. David Kupfer and Jan van Heek to serve until 2029), approving amendments to the Certificate of Incorporation to enable exculpation of certain officers and eliminate the exclusive forum provision, advisory votes on named executive officer compensation and say-on-pay frequency, and ratifying Deloitte & Touche LLP as auditors for FY 2026. As of the record date April 9, 2026, 43,841,998 shares of common stock and 3,296 shares of Series A Preferred Stock were outstanding.
- ·Annual Meeting accessible via live webcast at www.virtualshareholdermeeting.com/NERV2026; requires 16-digit control number.
- ·Stockholder list available for examination 10 days prior to meeting at principal offices or via email to info@minervaneurosciences.com, and during the meeting online.
23-04-2026
SELLAS Life Sciences Group, Inc. issued a DEF 14A proxy statement dated April 23, 2026, for its 2026 Annual Meeting of Stockholders to be held virtually on June 16, 2026, at 8:30 a.m. ET. Proposals include electing two Class I directors for a three-year term, ratifying Baker Tilly US, LLP as independent auditors for the fiscal year ending December 31, 2026, approving an amendment to increase shares under the 2023 Equity Plan by 20,000,000, advisory approval of named executive officer compensation, and authorizing adjournment if needed. As of the record date April 21, 2026, 184,532,574 shares of common stock were outstanding, requiring a quorum of 92,266,288 shares.
- ·Meeting held exclusively online via live webcast at www.virtualshareholdermeeting.com/SLS2026; no physical location.
- ·Stockholders of record as of April 21, 2026 entitled to vote; one vote per share of common stock.
- ·Proxy materials and 2026 Annual Report (Form 10-K for year ended December 31, 2025) available at www.proxyvote.com.
- ·List of stockholders available for inspection 10 days prior to meeting at company headquarters and during virtual meeting.
23-04-2026
Union Pacific reported first quarter 2026 net income of $1.7 billion, up 5% YoY from $1.6 billion, with diluted EPS of $2.87, up 6% YoY, and adjusted operating ratio improving 80 basis points to 59.9%. Operating revenue grew 3% to $6.2 billion, driven by 4% higher freight revenue, though total revenue carloads declined 1% and other revenues fell 4%. Operational metrics showed strong gains including 9% higher freight car velocity and 11% lower terminal dwell, but segments like intermodal (-6% revenue, -9% carloads) and premium (-5% revenue, -9% carloads) declined.
- ·2026 outlook affirmed with mid-single digit EPS growth, OR improvement, and $3.3 billion capital plan.
- ·Cash and equivalents decreased to $735 million at March 31, 2026 from $1,266 million at Dec 31, 2025.
- ·Merger costs of $36 million impacted reported EPS by $0.06.
23-04-2026
Axos Bank, a subsidiary of Axos Financial, Inc., entered into a Purchase and Assumption Agreement with Capital One, National Association on April 22, 2026, to acquire the IRA custodial business, including traditional and Roth IRA accounts (excluding Closed Accounts and Excluded Accounts), related Acquired Assets, and Assumed Liabilities such as Deposits in CD and Savings Accounts. The transaction includes a Deposit Premium Amount (redacted) based on aggregate Deposit balances as of Closing and requires Regulatory Approvals, including from the OCC under the Bank Merger Act. No specific quantitative portfolio sizes or values were disclosed.
- ·Cut-Off Date: seven (7) days prior to Closing Date
- ·Opt-Out Date: specified in Transfer Communication for account holder objections
- ·Closing effective at 12:01 a.m. Eastern time on Closing Date
- ·Knowledge defined by specific individuals for Seller (Rich Finn, David Roberts) and Purchaser (Greg Garrabrants, Derrick Walsh, Johnny Lai)
23-04-2026
Esquire Financial Holdings reported Q1 2026 net income of $12.2 million, up 7.0% YoY from $11.4 million, despite $1.7 million in elevated pretax noninterest expenses including $1.3 million merger costs for Signature Bancorporation and $398 thousand stock compensation charge, leading to declines in ROA to 2.10% from 2.39% and ROE to 16.82% from 19.13%. Total revenue grew 19.8% YoY to $40.5 million driven by 23.2% higher net interest income and resilient 6.04% NIM, with loans reaching $1.82 billion (up $56.7 million QoQ) and deposits $2.10 billion (up $39.6 million QoQ), though efficiency ratio worsened to 51.1% from 49.6%. The company increased its quarterly dividend 14% to $0.20 per share and made strong progress on the Signature acquisition.
- ·Allowance for credit losses to loans ratio of 1.30% (down from 1.37% YoY)
- ·Provision for credit losses $2.7 million (up $1.2 million YoY)
- ·Nonperforming loan to total assets ratio of 0.03%
- ·CET1 ratio 14.25%; TCE/TA ratio 12.44%
- ·Payment processing transactions 137.3 million (flat YoY detail not specified)
23-04-2026
Oregon Pacific Wealth Management, LLC filed its 13F-HR report disclosing 125 equity holdings totaling $95,849,214 as of March 31, 2026. The portfolio features significant allocations to ETFs such as Astoria US Quality (value $8,556,048), SPDR S&P 500 ($6,781,947), and iShares Core MSCI Emerging Markets ($4,061,891), alongside stocks including Alphabet Inc., Amazon.com Inc., Apple Inc., and Microsoft Corp. No period-over-period changes or performance metrics are provided in this point-in-time holdings snapshot.
- ·Filing date: April 23, 2026
- ·Report period end: March 31, 2026
- ·Business address: 3250 Hillcrest Park Drive, Suite 102, Medford, OR 97539-0076
- ·Phone: 541-858-0166
- ·Predominantly SOLE ownership; includes minor DFND and OTR positions
23-04-2026
SageGuard Financial Group, LLC filed its 13F-HR on April 23, 2026, disclosing total holdings of $646,253,841 across 196 positions as of March 31, 2026. The portfolio includes diversified equity and ETF positions with top holdings in Apple Inc. ($36,231,455), NVIDIA Corporation ($22,247,097), Amazon.com Inc. ($19,495,290), and Microsoft Corp. ($18,602,040). No period-over-period changes are detailed in the filing.
- ·Report period end date: March 31, 2026
- ·Filing CIK: 0001861378
23-04-2026
Univest Financial Corporation reported first quarter 2026 net income of $27.1 million, or $0.96 diluted EPS, a 24.7% increase from $22.4 million, or $0.77 EPS, in Q1 2025, supported by net interest income growth of 11.6% YoY to $63.4 million and noninterest income up 7.5% to $24.1 million. The company declared a quarterly dividend increase of 4.5% to $0.23 per share and repurchased 351,138 shares. However, total deposits decreased 3.9% QoQ, nonperforming assets rose to $41.2 million from $34.0 million YoY, noninterest expenses increased 6.8% YoY to $52.7 million, and BOLI income declined 32.0% YoY.
- ·Noninterest-bearing deposits represented 21.7% of total deposits at Q1 2026, up from 20.2% at Q4 2025.
- ·Unprotected deposits totaled $1.6 billion, or 23.7% of total deposits at Q1 2026, slightly up from 23.2% at Q4 2025.
- ·Share repurchases at average cost of $34.07 per share including fees.
- ·Conference call scheduled for April 23, 2026 at 9:00 a.m. EDT.
23-04-2026
Dupree Financial Group, LLC filed its 13F-HR report on April 23, 2026, disclosing equity holdings totaling $248,459,501 as of March 31, 2026, across 108 positions. Top holdings include Verizon Communications Inc at $14,491,921, BP PLC at $14,027,721, AGNC Investment Corp at $13,936,420, Enbridge Inc at $13,543,314, and Everest Group Ltd at $11,464,249. The filing provides a snapshot of the firm's portfolio with no period-over-period changes reported.
- ·Filing submitted from Lexington, KY
- ·SEC file number: 028-23564
- ·Investment advisor ID: 801-71497
23-04-2026
Muncy Columbia Financial Corporation (CCFN) filed an 8-K on April 23, 2026, announcing under Item 8.01 the issuance of a press release declaring a stock split, attached as Exhibit 99.1. The filing includes no additional financial details or metrics.
- ·Filing Type: 8-K (Items 8.01, 9.01)
- ·State of Incorporation: Pennsylvania
- ·Commission File Number: 000-19028
- ·I.R.S. Employer Identification No.: 23-2254643
- ·Principal Executive Offices: 1199 Lightstreet Road, Bloomsburg, PA 17815
23-04-2026
Capital City Bank Group, Inc. (CCBG) held its 2026 Annual Meeting of Shareowners on April 21, 2026. All twelve incumbent director nominees were elected to serve until the 2027 annual meeting, each receiving between 11,349,473 and 13,029,570 'For' votes against minimal opposition (maximum 1,750,517 'Against' for Stanley W. Connally, Jr.). Shareholders approved advisory executive compensation (12,879,981 For), recommended a 1-year frequency for future votes (12,051,728 votes), and ratified Forvis Mazars, LLP as the 2026 fiscal year independent auditor (14,821,583 For).
- ·Director votes detail: Stanley W. Connally, Jr. - 11,349,473 For, 1,750,517 Against; Laura L. Johnson - 11,857,263 For, 1,241,768 Against; all others had <621,422 Against
- ·Frequency vote: 186,356 for 2 Years, 11,651 Abstain
- ·Proxies solicited pursuant to Regulation 14A with no opposition to management
23-04-2026
C&F Financial Corporation held its Annual Meeting of Shareholders on April 21, 2026, with a quorum consisting of 2,687,415 shares present. Shareholders elected five Class III directors—Dr. Julie R. Agnew, J. P. Causey Jr., Thomas F. Cherry, Dr. David H. Downs, and George R. Sisson III—to serve until the 2029 Annual Meeting. All proposals were approved, including an advisory vote on named executive officers' compensation and ratification of Yount, Hyde & Barbour, P.C. as independent registered public accountant for the fiscal year ending December 31, 2026.
- ·Director election votes: Dr. Julie R. Agnew (For: 2,024,060; Withheld: 45,524); J. P. Causey Jr. (For: 2,008,497; Withheld: 61,087); Thomas F. Cherry (For: 2,044,072; Withheld: 25,512); Dr. David H. Downs (For: 2,045,224; Withheld: 24,360); George R. Sisson III (For: 2,017,825; Withheld: 51,759).
- ·Executive compensation advisory vote: For 2,044,164; Against 14,692; Abstention 10,891.
- ·Auditor ratification: For 2,641,796; Against 31,856; Abstention 13,763.
23-04-2026
Arrow Financial Corp (AROW) filed additional definitive proxy soliciting materials (DEFA14A) on April 23, 2026, supplementing the DEF 14A proxy statement filed the same day. The filing is part of routine governance disclosures with no financial metrics or period-over-period comparisons provided in the available metadata. Recent filings include an S-4 for business combinations on April 22, 2026, indicating potential M&A activity.
- ·Filing CIK: 0000717538
- ·Business address: 250 GLEN ST, GLENS FALLS, NY 12801
- ·SIC: 6021 - NATIONAL COMMERCIAL BANKS
- ·Fiscal Year End: December 31
23-04-2026
Blackston Financial Advisory Group, LLC filed its 13F-HR on April 23, 2026, disclosing 106 equity positions held as of March 31, 2026, with a total portfolio market value of $159,525,949. All reported holdings are under sole voting power with no shared discretion or options positions noted. Top holdings include Vanguard Index FDS SP 500 ETF SHS ($17,354,712), Vanguard World FD MEGA GRWTH IND ($16,209,683), and Vanguard Index FDS TOTAL STK MKT ($12,163,529).
- ·All holdings reported with sole voting power (SH SOLE) and no other manager discretion
- ·Business address: 8564 E. COUNTY ROAD 466, SUITE 302, THE VILLAGES, FL 32162
- ·Central Index Key: 0001910984
23-04-2026
Arrow Financial Corporation's DEF 14A proxy statement for the June 3, 2026 virtual annual meeting summarizes 2025 performance, including net income of $44.0 million ($2.65 per diluted share, +50% YoY EPS growth), net interest margin expansion to 3.19%, and tangible book value growth exceeding 10%, with Q4 ROAA surpassing 1.20%. The company completed its 'One Bank Weekend' integration, launching the unified Arrow Bank National Association brand. Community efforts reached over $1 million in giving to 424 organizations, supported by 13,700 employee volunteer hours.
- ·Proxy statement includes Pay vs. Performance disclosures for PEO (David S. DeMarco, Thomas J. Murphy) and Non-PEO NEOs covering 2021-2025.
- ·Annual Meeting at 10:00 a.m. on June 3, 2026, hosted virtually via arrowfinancial.com.
23-04-2026
SB Financial Group, Inc. (NASDAQ: SBFG) announced a quarterly cash dividend of $0.16 per common share, payable on May 29, 2026, to shareholders of record as of May 15, 2026. This dividend marks a 7% increase from the prior year's quarterly dividend of $0.15 per share and a 7% rise over the previous four quarters ($0.62 vs. $0.58), representing a 2.8% yield. The company reported 6,281,820 common shares outstanding as of April 23, 2026.
- ·Dividend declared by Board of Directors on April 22, 2026.
- ·Headquartered in Defiance, OH, with 27 offices and 27 ATMs.
23-04-2026
Rector, Church-Wardens & Vestrymen of Trinity Church in the city of New-York filed a 13F-HR report on April 23, 2026, disclosing equity holdings as of March 31, 2026, totaling $431,347,522 across two positions held solely. The portfolio consists of iShares TR MSCI ACWI ETF valued at $255,691,156 (1,847,880 shares) and ETF SERIES TRUST EAGLE CAPITAL SE valued at $175,656,366 (5,774,371 shares). No prior period data is provided for comparison.
- ·Central Index Key: 0001729522
- ·SEC File Number: 028-18375
- ·Business address: 76 Trinity Place, 10th Floor, New York, NY 10006
23-04-2026
First Business Financial Services reported Q1 2026 net income available to common shareholders of $12.0 million ($1.44 diluted EPS), down from $13.1 million ($1.58) in Q4 2025 but up from $11.0 million ($1.32) in Q1 2025, driven by robust loan growth of $125.9 million (14.9% annualized) QoQ and $315.9 million (9.9%) YoY, and core deposit growth of $123.1 million (18.4% annualized) QoQ and $333.4 million (13.5%) YoY. However, net interest margin contracted to 3.56% from 3.53% QoQ and 3.69% YoY, provision for credit losses rose to $3.0 million from $1.9 million QoQ and $2.7 million YoY, and non-performing assets increased YoY to 0.94% of total assets from 0.61%. Non-interest income grew 15.8% YoY, supporting 13.6% YoY tangible book value per share growth.
- ·Efficiency ratio 61.14% in Q1 2026, up from 56.61% in Q4 2025.
- ·Return on average tangible common equity 13.55% in Q1 2026, down from 14.83% in Q4 2025.
- ·Allowance for credit losses 1.10% of total gross loans Q1 2026, down from 1.12% QoQ.
- ·Private wealth assets under management and administration $3.881 billion at March 31, 2026, up 13.3% YoY.
23-04-2026
Franklin Financial Services Corp reported Q1 2026 net income of $6.6 million ($1.48 per diluted share), up 69.2% YoY from $3.9 million ($0.88 per share) and 9.8% QoQ from $6.0 million, driven by 18.7% higher net interest income to $18.5 million and improved ROA of 1.20% (vs 0.72% YoY) and NIM of 3.53% (vs 3.05% YoY). Total assets grew 2.6% QoQ to $2.298 billion with deposits up 2.9% to $1.890 billion, but net loans increased only 0.7% to $1.552 billion amid a $11.5 million drop in commercial loans, debt securities fell 4.0% due to paydowns, and net unrealized investment losses widened to $28.8 million from $26.8 million. The board declared a quarterly dividend of $0.34 per share (up 3.0% YoY) payable May 27, 2026 to shareholders of record May 1, 2026.
- ·Nonaccrual loans at $8.5 million (0.54% of gross loans) on March 31, 2026, materially unchanged QoQ; primarily $7.7 million CRE across four loans.
- ·Specific reserve increased to $1.0 million on $7.0 million nonaccrual CRE construction loan; additional $557 thousand reserve on $621 thousand C&I loan.
- ·Allowance for credit losses to loans ratio unchanged at 1.32%; ACL for unfunded commitments $1.9 million, unchanged.
- ·Bank considered 'well-capitalized' under regulatory guidelines as of March 31, 2026.
- ·89% of deposits FDIC insured or collateralized as of March 31, 2026.
- ·Book value $39.78 per share; tangible book value $37.78 per share as of March 31, 2026.
23-04-2026
Equita Financial Network, Inc. filed its 13F-HR on April 23, 2026, reporting holdings as of March 31, 2026, across 87 positions with a total market value of $318.0 billion, predominantly in ETFs and select large-cap stocks. Top holdings include Vanguard Total Stock Market ETF at $48.3 billion and Vanguard Tax-Managed Funds FTSE Developed Markets ETF at $32.7 billion, alongside positions in Alphabet Inc., Amazon.com Inc., and Apple Inc. The portfolio reflects sole discretionary ownership with no reported shared voting authority or other managers.
- ·All positions held with sole discretionary voting power (SH SOLE); no put/call options, shared power, or other managers reported
- ·Period end date: March 31, 2026
- ·File number: 028-23412
23-04-2026
Exeter Financial, LLC disclosed its quarterly 13F-HR holdings totaling $244876454 across 98 positions as of March 31, 2026, with all positions held under sole discretionary authority and no shared voting or investment discretion. Top holdings by value include iShares TR Ultra Short Dur at $12822867 (253316 shares), First TR Enhanced Equity at $11812044 (579022 shares), Vanguard BD Index FDS Short TRM Bond at $10819953 (137992 shares), Apple Inc at $10143829 (39969 shares), and Dimensional ETF Trust US Core EQT MKT at $4545187 (100736 shares). The portfolio features a mix of individual equities, ETFs, and fixed income products with no reported changes or performance metrics.
- ·Filing date: April 23, 2026
- ·Report period end: March 31, 2026
- ·CIK: 0001752045
- ·Business address: 7001 N. Scottsdale Road, Suite 1055, Scottsdale, AZ 85253-3644
- ·Phone: 480 588-0830
23-04-2026
Solid Biosciences Inc. (SLDB) has filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting on June 10, 2026, at 8:00 AM ET virtually. Shareholders are asked to vote on electing Class II directors Clare Kahn, Adam Stone, and Lynne Sullivan; ratifying Ilan Ganot as a Class I director until the 2028 annual meeting; approving PricewaterhouseCoopers LLP as auditors for FY 2026; amending the Certificate of Incorporation to double authorized common shares from 240,000,000 to 480,000,000; and an advisory vote on executive compensation. No financial performance metrics are disclosed in the filing.
- ·Annual Meeting vote deadline: June 9, 2026, 11:59 PM ET
- ·Proxy material request deadline: May 27, 2026
- ·Virtual meeting site: www.virtualshareholdermeeting.com/SLDB2026
- ·Fiscal year for auditor ratification: ending December 31, 2026
23-04-2026
At the Annual Meeting of Shareholders on April 23, 2026, all ten director nominees were elected with strong support, receiving between 18,632,007 and 19,101,812 votes for (approximately 93-99% of participating votes). The non-binding advisory vote on named executive officer compensation passed with 13,616,250 votes for (70.9%) but faced significant opposition with 5,589,906 votes against (29.1%). Shareholders overwhelmingly ratified Crowe LLP as the independent auditor with 20,327,507 votes for (99.2%).
- ·Broker non-votes totaled 1,278,530 across all proposals.
- ·Executive compensation abstentions: 10,860 votes.
- ·Auditor ratification had 166,094 votes against and 1,945 abstentions.
23-04-2026
Edgewise Therapeutics, Inc. filed a Definitive Additional Proxy Statement (DEFA14A) on April 23, 2026, for its 2026 Annual Meeting of Stockholders on June 4, 2026, at 10:00 am MT in Boulder, Colorado. Shareholders will vote on electing directors Laura Brege, Badreddin Edris, Ph.D., and Jonathan Root, M.D. to serve until the 2029 Annual Meeting, ratifying KPMG LLP as independent auditors for the fiscal year ending December 31, 2026, and an advisory vote approving named executive officer compensation, with the board recommending 'For' on all items. Proxy materials are available online at www.ProxyVote.com or by request before May 21, 2026, with voting deadline June 3, 2026, 11:59 PM ET.
- ·Meeting location: 1715 38th Street, Boulder, Colorado 80301
- ·Vote by Internet, telephone, or mail; in-person voting requires requesting a ballot
23-04-2026
Inhibrx Biosciences, Inc. (INBX) filed a DEFA14A Definitive Additional Materials proxy statement on April 23, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing is marked as Definitive Additional Materials with no fee required. No financial metrics, operational updates, or specific proposals are detailed in the provided filing header.
23-04-2026
Financial Institutions, Inc. reported net income of $21.0 million for Q1 2026, up from $16.9 million in Q1 2025 and $20.0 million in Q4 2025, with net income available to common shareholders at $20.6 million or $1.04 per diluted share, reflecting a 28.4% YoY EPS increase, NIM expansion of 32 basis points to 3.67%, ROA of 1.37%, ROE of 13.43%, and efficiency ratio of 57%. Total loans grew 1.6% YoY to $4.63 billion driven by commercial lending, while deposits increased 2.5% QoQ to $5.34 billion. However, deposits declined 0.7% YoY due to BaaS wind-down, loans fell 0.7% QoQ, consumer indirect loans dropped 7.7% YoY, and noninterest income decreased to $10.7 million from $11.9 million in Q4 2025.
- ·Commercial business loans up 5.3% YoY to $746.4 million.
- ·Commercial mortgage loans up 4.6% YoY to $2.33 billion.
- ·Residential real estate loans up 1.4% YoY to $652.9 million.
- ·Share repurchase at average price of $31.50 per share.
- ·Quarterly cash dividend increased to $0.32 per common share.
- ·ROTCE increased 168 basis points YoY to 15.04%.
- ·Public deposits represented 23% of total deposits at March 31, 2026.
23-04-2026
Burke & Herbert Financial Services Corp. reported Q1 2026 net income applicable to common shares of $27.1 million ($1.79 diluted EPS), down from $30.0 million ($1.98 EPS) in Q4 2025, while adjusted operating net income was $28.2 million ($1.87 EPS); loans grew modestly to $5.4 billion but deposits declined to $6.3 billion, with net interest income falling to $71.8 million and NIM contracting slightly to 4.09%. The board declared a $0.55 per share dividend payable June 1, 2026, asset quality remained solid with provision expense of $213 thousand, and the company received regulatory approval for its merger with LINKBANCORP Inc., expected to close May 1, 2026. Strong capital ratios (CET1 13.8%) and liquidity ($4.8 billion) position the balance sheet well, delivering ROA of 1.39% and ROE of 12.62%.
- ·New loan originations: $132.0 million in Q1 2026.
- ·Core deposits decreased $10.7 million QoQ, excluding $61.0 million drop in brokered deposits.
- ·Provision expense: $213.0 thousand on loans, recapture of $201.0 thousand on unfunded commitments.
- ·Accretion income on loans: $6.8 million Q1 2026 vs. $8.7 million Q4 2025.
- ·Bank subsidiary ratios: CET1 15.2%, Total RBC 16.3%, Leverage 12.0% (estimated Q1 2026).
23-04-2026
This 10-K/A filing for Canadian Pacific Kansas City Ltd (CP) details director skills and qualifications across multiple areas including senior executive leadership, financial expertise, transportation industry knowledge, and safety/climate expertise. In the 2025 STIP scorecard, the company met its operating ratio target at 60.4% (100% score) and exceeded safety targets with FRA Train Accident Frequency at 0.85 (200% score) and FRA Personal Injury Frequency at 0.92 (200% score), but missed the operating income target with $6,112 million actual vs. $6,216 million target (73% score), yielding a 121% corporate performance factor for NEOs.
- ·Director skills include senior executive leadership, accounting & financial literacy/expertise, environment/health/safety and climate expertise, executive compensation/human resources, transportation industry knowledge, governance, government/regulatory affairs and legal, risk management, sales & marketing, strategic oversight, investment management, and information technology.
- ·President and Chief Executive Officer appointed January 31, 2017.
- ·STIP targets adjusted for 2025 due to foreign exchange rates and 2024 regulatory changes, leading to slight YoY increase in operating ratio targets.
23-04-2026
Inhibrx Biosciences, Inc. (INBX) filed its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders, to be held virtually on June 3, 2026, at 10:00 a.m. Pacific Time. Shareholders of record as of April 7, 2026, when 14,607,286 shares of common stock were outstanding, will vote on Proposal 1: election of Class II directors, and Proposal 2: ratification of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026. Proxy materials and the Annual Report on Form 10-K for the year ended December 31, 2025, are available at https://www.proxydocs.com/INBX.
- ·Virtual meeting registration required at https://www.proxydocs.com/INBX by 10:00 a.m. PT on June 3, 2026, using control number.
- ·Proxy distribution began on or about April 23, 2026.
- ·Board recommends voting 'FOR' both proposals.
23-04-2026
Principal Financial Group reported strong Q1 2026 non-GAAP operating earnings of $456.1 million, up 10% YoY, with diluted EPS excluding significant variances at $2.17, up 13% YoY, and returned $374 million to shareholders via $200 million share repurchases and $174 million dividends, alongside an 8% dividend increase to $0.82 per share for Q2. AUM grew 7% to $770.2 billion and AUA to $1,788.5 billion, driven by segment growth including Specialty Benefits pre-tax earnings up 29% to $136.8 million and International Pension up 17% to $83.4 million. However, Corporate pre-tax operating losses widened 16% to $122.1 million, and AUM net cash flow remained negative at $1.5 billion despite a $2.9 billion YoY improvement.
- ·Q2 2026 dividend payable June 26, 2026 to shareholders of record June 1, 2026.
- ·Earnings conference call scheduled for April 24, 2026 at 10:00 a.m. ET.
- ·Incurred loss ratio in Specialty Benefits improved to 58.5% from 60.7% YoY.
23-04-2026
Lifeward Ltd. announced that Jeannine Lynch's employment as Vice President of Strategy and Market Access will terminate effective May 3, 2026, pursuant to notice on April 20, 2026, treated as without cause under her Employment Agreement dated July 9, 2021. Ms. Lynch will receive severance and benefits in accordance with the agreement, details of which were disclosed in the company's Form 10-K filed March 18, 2026. No successor has been named.
- ·Termination notice provided on April 20, 2026.
- ·Form 8-K filed on April 23, 2026.
23-04-2026
Foundry Financial Group, Inc. filed its 13F-HR report on April 23, 2026, disclosing total equity holdings of $201,554,562 across 70 positions as of March 31, 2026. The portfolio is diversified with significant allocations to ETFs such as iShares Core S&P 500 ETF ($20,101,962), iShares Core MSCI EAFE ETF ($12,130,205), and BlackRock ETF Trust iShares US Equity ($12,224,555), alongside individual stocks including Apple Inc. ($1,005,770), NVIDIA Corporation ($1,173,886), and Alphabet Inc. (Class A: $406,035; Class C: $554,787). No prior period comparisons are provided in the filing.
- ·Filing CIK: 0002007960
- ·SEC File Number: 028-23521
- ·Business Address: 67 Water Street Suite 101, Laconia, NH 03246
- ·Fiscal Year End: 09-30
- ·Other holdings include Amazon.com Inc. ($507,346), Berkshire Hathaway Inc. Del Cl B New ($237,683), Microsoft Corp. ($772,915)
23-04-2026
Solid Biosciences Inc. (SLDB) has issued a proxy statement for its Annual Stockholders Meeting on June 10, 2026, seeking approval for the election of three Class II directors (Clare Kahn, Adam Stone, Lynne Sullivan), advisory ratification of Ilan Ganot as a Class I director, ratification of PricewaterhouseCoopers LLP as auditors for FY 2026, an amendment to increase authorized common shares from 240,000,000 to 480,000,000, and an advisory vote on executive compensation. As of the Record Date April 16, 2026, there were 98,413,277 shares of common stock outstanding. No financial performance metrics or period-over-period comparisons are detailed in the filing.
- ·Annual Meeting to be held virtually at http://www.virtualshareholdermeeting.com/SLDB2026 on June 10, 2026 at 8:00 a.m. Eastern Time
- ·Record Date: April 16, 2026
- ·Notice mailing scheduled to begin on or about April 23, 2026
23-04-2026
Waterstone Financial reported Q1 2026 consolidated net income of $6.0 million ($0.34 diluted EPS), doubling from $3.0 million ($0.17 EPS) in Q1 2025, fueled by Community Banking's record net interest income of $15.2 million (up 22.8% YoY) and NIM expansion to 2.97% (up 50 bps YoY), alongside Mortgage Banking's shift to $22K pre-tax income from a $2.2 million loss on 31.1% higher loan originations of $508.3 million. However, provision for credit losses rose to $264K from a $558K credit YoY due to qualitative factors and higher loan balances, Mortgage Banking gross margin declined to 3.65% from 3.98%, compensation expenses increased 20.1%, and average loans held for investment grew only 0.2% YoY to $1.68 billion while declining QoQ.
- ·Nonperforming assets ratio stable at 0.35% at March 31, 2026 (same as Q1 2025, up from 0.29% at Dec 31, 2025).
- ·Past due loans ratio 0.58% at March 31, 2026 (improved from 0.86% QoQ but up from 0.67% YoY).
- ·Dividends declared $0.17 per share Q1 2026.
- ·Book value per share $19.19 at March 31, 2026 (up from $19.03 at Dec 31, 2025).
- ·Total assets $2,251 million at March 31, 2026 (down from $2,260 million at Dec 31, 2025).
Get daily alerts with 12 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings
More from: S&P 500 Healthcare Sector SEC Filings
🇺🇸 More from United States
View all →April 16, 2026
US Pre-Market SEC Filings Roundup — April 16, 2026
US Pre-Market SEC Filings Roundup
April 16, 2026
Nasdaq 100 Stocks SEC Filings — April 16, 2026
Nasdaq 100 Stocks SEC Filings
April 16, 2026
All NASA Contracts — April 16, 2026
All NASA Contracts
April 16, 2026
US Merger & Acquisition SEC Filings — April 16, 2026
US Merger & Acquisition SEC Filings